Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-15.32%
Shrank
—
-81.57%
Shrank
—
1 Year
Score—
Net Growth-15.32%
Net TrendShrank
Net Income Consistency—
Rev Growth-81.57%
Rev TrendShrank
Revenue Consistency—
Entrada Therapeutics Inc fundamental performance
Across Entrada Therapeutics Inc's full reported history, from 2021 to 2025, revenue grew from $ 0.00 to $ 25M and net income went from -$ 50M to -$ 143M. Revenue increased in 60% of the years measured; net income in 40%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.67 | — |
1 Year2025-08-12 | $ 5.16 | 48.64% |
All Time2021-10-29 | $ 23.95 | -67.97% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-10-29 |
|---|---|---|---|
| Price | $ 7.67 | $ 5.16 | $ 23.95 |
| Return | — | 48.64% | -67.97% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 4M | -$ 165M | $ 223M |
| 2025 | $ 25M | -$ 143M | $ 295M |
| 2024 | $ 210M | $ 65M | $ 419M |
| 2023 | $ 129M | -$ 6M | $ 351M |
| 2022 | $ 25M | -$ 87M | $ 188M |
| IPO2021 | $ 0.00 | -$ 50M | $ 291M |
Explore beyond TRDA
You're looking at Entrada Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
